IL42145A0 - Reduction of body weight in mammals and compositions therefor comprising a mixture of carnitine and one or more lipolytic factor - Google Patents

Reduction of body weight in mammals and compositions therefor comprising a mixture of carnitine and one or more lipolytic factor

Info

Publication number
IL42145A0
IL42145A0 IL42145A IL4214573A IL42145A0 IL 42145 A0 IL42145 A0 IL 42145A0 IL 42145 A IL42145 A IL 42145A IL 4214573 A IL4214573 A IL 4214573A IL 42145 A0 IL42145 A0 IL 42145A0
Authority
IL
Israel
Prior art keywords
carnitine
mammals
reduction
mixture
body weight
Prior art date
Application number
IL42145A
Other languages
English (en)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL42145A0 publication Critical patent/IL42145A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL42145A 1972-05-11 1973-04-30 Reduction of body weight in mammals and compositions therefor comprising a mixture of carnitine and one or more lipolytic factor IL42145A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2210572A GB1435916A (en) 1972-05-11 1972-05-11 Pharmaceutical weight-reducing compositions

Publications (1)

Publication Number Publication Date
IL42145A0 true IL42145A0 (en) 1973-06-29

Family

ID=10173983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42145A IL42145A0 (en) 1972-05-11 1973-04-30 Reduction of body weight in mammals and compositions therefor comprising a mixture of carnitine and one or more lipolytic factor

Country Status (8)

Country Link
JP (1) JPS4947519A (enExample)
AU (1) AU5561973A (enExample)
BE (1) BE799141A (enExample)
DE (1) DE2323906A1 (enExample)
FR (1) FR2183979A1 (enExample)
GB (1) GB1435916A (enExample)
IL (1) IL42145A0 (enExample)
NL (1) NL7306507A (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
FR2619007B1 (fr) * 1987-08-07 1990-09-28 Dermatologiques Et Preparations cosmetiques a action lipolytique
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
EP0697020A1 (en) * 1993-05-06 1996-02-21 Merrell Pharmaceuticals Inc. 8-substituted xanthines as selective adenosine receptor agents
AT413943B (de) * 2004-03-05 2006-07-15 Lohninger Alfred Dr L-carnitin enthaltende, oral verabreichbare zusammensetzung
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Also Published As

Publication number Publication date
AU5561973A (en) 1974-11-14
DE2323906A1 (de) 1973-11-22
FR2183979A1 (enExample) 1973-12-21
GB1435916A (en) 1976-05-19
JPS4947519A (enExample) 1974-05-08
BE799141A (fr) 1973-11-05
NL7306507A (enExample) 1973-11-13

Similar Documents

Publication Publication Date Title
HK57678A (en) Improvements in and relating to the dispensing of fasteners
GB1551082A (en) Package for the separate storage and mixing of different materials
PH12097A (en) Pharmaceutically active pepiide and composition thereof
ZA746051B (en) Improvements in and relating to the storage of continuous material
GB1400540A (en) Salicylamides and compositions thereof
IL39988A0 (en) Pyrazolopyrimidines and pharmaceutical compositions containing them
IL42145A0 (en) Reduction of body weight in mammals and compositions therefor comprising a mixture of carnitine and one or more lipolytic factor
ZA737964B (en) Improvements in or relating to the mixing and dispensing of multiconstituent compositions
ZA724075B (en) Preparation of polyolefins with peroxide end-groups and their use in the synthesis of block copolumers
IL47535A0 (en) 7-methoxy-6-thiatetracyclines and their preparation
AU6198673A (en) Powdered coating compositions preparation and use
GB1365661A (en) Prparation of medicinal and food compositions
PH9827A (en) Derivatives of 1-phenoxy-3-amino-propane-2-ol and composition thereof
GB1393206A (en) Resin and coating composition containing it
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ179598A (en) Cephalosporins and pharmaceutical compositions
JPS5223010A (en) Preparation and use of 1*11 dichlorr44methyll33hydroxyy bentt11en
IE39291B1 (en) Pharmaceutical compositions comprising an anzyme and substtrate
IL45821A0 (en) Biphenylyl esters and their preparation
ZA724068B (en) Improvements in and relating to the preparation of group viii metal compounds
NZ181626A (en) 3-holo-cephalosporins and pharmaceutical compositions
JPS5277074A (en) Novel daunosaminnucleoside and its preparation and pharmaceutical composition having antiitumor effect containign same
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
ZA733762B (en) Combustible compositions and method of use